BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 30250188)

  • 1. CCL19 suppresses angiogenesis through promoting miR-206 and inhibiting Met/ERK/Elk-1/HIF-1α/VEGF-A pathway in colorectal cancer.
    Xu Z; Zhu C; Chen C; Zong Y; Feng H; Liu D; Feng W; Zhao J; Lu A
    Cell Death Dis; 2018 Sep; 9(10):974. PubMed ID: 30250188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-148a inhibits early relapsed colorectal cancers and the secretion of VEGF by indirectly targeting HIF-1α under non-hypoxia/hypoxia conditions.
    Tsai HL; Miao ZF; Chen YT; Huang CW; Yeh YS; Yang IP; Wang JY
    J Cell Mol Med; 2019 May; 23(5):3572-3582. PubMed ID: 30834693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jianpi Jiedu decoction, a traditional Chinese medicine formula, inhibits tumorigenesis, metastasis, and angiogenesis through the mTOR/HIF-1α/VEGF pathway.
    Peng W; Zhang S; Zhang Z; Xu P; Mao D; Huang S; Chen B; Zhang C; Zhang S
    J Ethnopharmacol; 2018 Oct; 224():140-148. PubMed ID: 29852266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
    Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
    Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer.
    Chen C; Xu ZQ; Zong YP; Ou BC; Shen XH; Feng H; Zheng MH; Zhao JK; Lu AG
    Cell Death Dis; 2019 Feb; 10(3):178. PubMed ID: 30792394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of connective tissue growth factor on hypoxia-inducible factor 1alpha degradation and tumor angiogenesis.
    Chang CC; Lin MT; Lin BR; Jeng YM; Chen ST; Chu CY; Chen RJ; Chang KJ; Yang PC; Kuo ML
    J Natl Cancer Inst; 2006 Jul; 98(14):984-95. PubMed ID: 16849681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor efficacy of CC motif chemokine ligand 19 in colorectal cancer.
    Lu J; Zhao J; Feng H; Wang P; Zhang Z; Zong Y; Ma J; Zheng M; Lu A
    Dig Dis Sci; 2014 Sep; 59(9):2153-62. PubMed ID: 24705643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginine ADP-ribosyltransferase 1 promotes angiogenesis in colorectal cancer via the PI3K/Akt pathway.
    Yang L; Xiao M; Li X; Tang Y; Wang YL
    Int J Mol Med; 2016 Mar; 37(3):734-42. PubMed ID: 26847718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels.
    Ding C; Luo J; Fan X; Li L; Li S; Wen K; Feng J; Wu G
    J Exp Clin Cancer Res; 2017 Apr; 36(1):56. PubMed ID: 28420432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR6 promotes tumor angiogenesis via the AKT/NF-κB/VEGF pathway in colorectal cancer.
    Zhu CC; Chen C; Xu ZQ; Zhao JK; Ou BC; Sun J; Zheng MH; Zong YP; Lu AG
    Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):387-397. PubMed ID: 29097259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NT5DC2 knockdown inhibits colorectal carcinoma progression by repressing metastasis, angiogenesis and tumor-associated macrophage recruitment: A mechanism involving VEGF signaling.
    Zhu Z; Hou Q; Guo H
    Exp Cell Res; 2020 Dec; 397(1):112311. PubMed ID: 32991874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-206 attenuates the growth and angiogenesis in non-small cell lung cancer cells by blocking the 14-3-3ζ/STAT3/HIF-1α/VEGF signaling.
    Xue D; Yang Y; Liu Y; Wang P; Dai Y; Liu Q; Chen L; Shen J; Ju H; Li Y; Tan Z
    Oncotarget; 2016 Nov; 7(48):79805-79813. PubMed ID: 27806334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast activation protein-α in tumor cells promotes colorectal cancer angiogenesis via the Akt and ERK signaling pathways.
    Cao F; Wang S; Wang H; Tang W
    Mol Med Rep; 2018 Feb; 17(2):2593-2599. PubMed ID: 29207091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTGF increases vascular endothelial growth factor-dependent angiogenesis in human synovial fibroblasts by increasing miR-210 expression.
    Liu SC; Chuang SM; Hsu CJ; Tsai CH; Wang SW; Tang CH
    Cell Death Dis; 2014 Oct; 5(10):e1485. PubMed ID: 25341039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
    Ding C; Li L; Yang T; Fan X; Wu G
    BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocyte enhancer factor 2D promotes colorectal cancer angiogenesis downstream of hypoxia-inducible factor 1α.
    Xiang J; Sun H; Su L; Liu L; Shan J; Shen J; Yang Z; Chen J; Zhong X; Ávila MA; Yan X; Liu C; Qian C
    Cancer Lett; 2017 Aug; 400():117-126. PubMed ID: 28478181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitor of growth 4 suppresses colorectal cancer growth and invasion by inducing G1 arrest, inhibiting tumor angiogenesis and reversing epithelial-mesenchymal transition.
    Qu H; Yin H; Yan S; Tao M; Xie Y; Chen W
    Oncol Rep; 2016 May; 35(5):2927-35. PubMed ID: 26936485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-181a promotes angiogenesis in colorectal cancer by targeting SRCIN1 to promote the SRC/VEGF signaling pathway.
    Sun W; Wang X; Li J; You C; Lu P; Feng H; Kong Y; Zhang H; Liu Y; Jiao R; Chen X; Ba Y
    Cell Death Dis; 2018 Apr; 9(4):438. PubMed ID: 29739921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P53-induced miR-1249 inhibits tumor growth, metastasis, and angiogenesis by targeting VEGFA and HMGA2.
    Chen X; Zeng K; Xu M; Liu X; Hu X; Xu T; He B; Pan Y; Sun H; Wang S
    Cell Death Dis; 2019 Feb; 10(2):131. PubMed ID: 30755600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.